These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Uncommon presentations of Hodgkin's disease. Case 3. Hodgkin's disease: rectal presentation. Simpson L; Taylor S; Piotrowski A J Clin Oncol; 2004 Jan; 22(1):196-8. PubMed ID: 14701784 [No Abstract] [Full Text] [Related]
23. [Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications]. Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M Przegl Lek; 2004; 61 Suppl 2():33-9. PubMed ID: 15688474 [TBL] [Abstract][Full Text] [Related]
24. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials. Noordijk EM; Carde P; Dupouy N; Hagenbeek A; Krol AD; Kluin-Nelemans JC; Tirelli U; Monconduit M; Thomas J; Eghbali H; Aleman BM; Bosq J; Vovk M; Verschueren TA; Pény AM; Girinsky T; Raemaekers JM; Henry-Amar M J Clin Oncol; 2006 Jul; 24(19):3128-35. PubMed ID: 16754934 [TBL] [Abstract][Full Text] [Related]
25. [Primary treatment of advanced Hodgkin's disease]. Illés A; Udvardy M; Molnár Z Orv Hetil; 2005 Jan; 146(5):195-202. PubMed ID: 15773586 [TBL] [Abstract][Full Text] [Related]
26. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A; J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521 [TBL] [Abstract][Full Text] [Related]
28. Doxorubicin, bleomycin, vinblastine, and dacarbazine alone in treatment of favorable, limited-stage Hodgkin's lymphoma: do we really have robust data? Basaran G; Agaoglu F; Basaran M J Clin Oncol; 2010 Sep; 28(27):e485-6; author reply e487. PubMed ID: 20606082 [No Abstract] [Full Text] [Related]
29. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma]. Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685 [TBL] [Abstract][Full Text] [Related]
30. Hodgkin's lymphoma in adolescents. Foltz LM; Song KW; Connors JM J Clin Oncol; 2006 Jun; 24(16):2520-6. PubMed ID: 16735704 [TBL] [Abstract][Full Text] [Related]
31. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation. Chow LM; Nathan PC; Hodgson DC; Jenkin D; Weitzman S; Grant RM; Manson D; Bross A; Doyle JJ; Danjoux C; Greenberg ML J Clin Oncol; 2006 Dec; 24(36):5735-41. PubMed ID: 17179107 [TBL] [Abstract][Full Text] [Related]
32. [Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy]. Pivnik AV; Rastrigin NA; Moiseeva TN; Lutsenko IN; Dudarova RG; Shavlokhov VS; Efimov IV; Kozhurin SV; Shitareva IV; Gemdzhian EG; Tsyba NN; Kolosova LIu; Melikian AL; Skidan NI; Pan'shin GA; Sotnikov VM; Dotsenko PV; Nechistiuk AV Ter Arkh; 2006; 78(8):57-62. PubMed ID: 17078219 [TBL] [Abstract][Full Text] [Related]
34. [Relapse of Hodgkin disease after 17 years of complete remission. A case report]. Osorio G; Caglevic C Rev Med Chil; 2003 Feb; 131(2):197-9. PubMed ID: 12708259 [TBL] [Abstract][Full Text] [Related]
35. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation. Sénécal D; Jais JP; Desablens B; Berthou C; Casassus P; Moles MP; Delwail V; Gastinne T; Colonna P; Andrieu JM Cancer; 2008 Feb; 112(4):846-55. PubMed ID: 18072259 [TBL] [Abstract][Full Text] [Related]
36. Radiotherapy and Hodgkin's lymphoma. Das P; Ha CS; Cox JD J Clin Oncol; 2005 Dec; 23(34):8914; author reply 8914-6. PubMed ID: 16314655 [No Abstract] [Full Text] [Related]
37. Membranous glomerulonephritis in a patient with Hodgkin's lymphoma in remission. Sánchez M; Enríquez R; Sirvent AE; Heredia L; Millán I; Amorós F Nefrologia; 2013; 33(5):745-7. PubMed ID: 24089174 [No Abstract] [Full Text] [Related]
38. Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil. Hsu SC; Metzger ML; Hudson MM; Pedrosa F; Lins M; Pedrosa M; Barros C; Maciel K; Pui CH; Ribeiro RC; Howard SC Pediatr Blood Cancer; 2007 Aug; 49(2):139-44. PubMed ID: 16642484 [TBL] [Abstract][Full Text] [Related]
39. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease. Villani F; Busia A; Villani M; Laffranchi A; Viviani S; Bonfante V Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235 [TBL] [Abstract][Full Text] [Related]
40. Stanford V and radiotherapy for Hodgkin's disease. Portlock CS Curr Oncol Rep; 2002 Sep; 4(5):413. PubMed ID: 12162915 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]